about
A genomewide association study of citalopram response in major depressive disorderThe 5-HT deficiency theory of depression: perspectives from a naturalistic 5-HT deficiency model, the tryptophan hydroxylase 2Arg439His knockin mouseGenetic determinants of depression: recent findings and future directionsKetamine influences CLOCK:BMAL1 function leading to altered circadian gene expressionA systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.Time-varying SMART design and data analysis methods for evaluating adaptive intervention effectsElectroconvulsive therapy mediates neuroplasticity of white matter microstructure in major depressionDopamine genetic risk score predicts depressive symptoms in healthy adults and adults with depression.Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults.A genome-wide association study of a sustained pattern of antidepressant responseCircadian dysregulation of clock genes: clues to rapid treatments in major depressive disorder.A functional alternative splicing mutation in human tryptophan hydroxylase-2.Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study.The combination of olanzapine and fluoxetine in mood disorders.Current perspectives in the management of treatment-resistant depression.Use of treatment algorithms for depressionRationale and methods for site selection for a trial using a novel intervention to treat stimulant abuseA genomewide association study points to multiple loci that predict antidepressant drug treatment outcome in depressionTherapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.Structural Plasticity of the Hippocampus and Amygdala Induced by Electroconvulsive Therapy in Major Depression.Somatic drugs for psychiatric diseases: aspirin or simvastatin for depression?Children of depressed mothers 1 year after remission of maternal depression: findings from the STAR*D-Child studyUse of antiepileptic drugs for nonepileptic conditions: psychiatric disorders and chronic pain.Superior antidepressant effect occurring 1 month after rTMS: add-on rTMS for subjects with medication-resistant depression.Statistical methods for analyzing sequentially randomized trialsThe drugs don't work? antidepressants and the current and future pharmacological management of depression.The effect of telephone-facilitated depression care on older, medically ill patients.Repeated acupuncture treatments modulate amygdala resting state functional connectivity of depressive patients.Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.Innovations in clinical research design and conduct in psychiatry: shifting to pragmatic approachesCurrent electroconvulsive therapy practice and research in the geriatric populationBayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity.Genomewide interaction and enrichment analysis on antidepressant response.The Psycho-Neurology of Cross-Species Affective/Social Neuroscience: Understanding Animal Affective States as a Guide to Development of Novel Psychiatric Treatments.Cell-type-specific role for nucleus accumbens neuroligin-2 in depression and stress susceptibility.Adherence to guidelines and effectiveness of inpatient treatment for unipolar depression.Executive summary of the report by the WPA section on pharmacopsychiatry on general and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders.General and comparative efficacy and effectiveness of antidepressants in the acute treatment of depressive disorders: a report by the WPA section of pharmacopsychiatry.
P2860
Q24656746-20080F1F-E7A6-449E-A0C9-101F235D3EF0Q26849351-E6BA15D7-D167-4D22-BFEC-1EA9851A9C68Q27027836-4B361AD2-B8A0-49EB-9034-6785FD8E24FEQ28476686-09060A24-7308-4A75-B0C3-6311B79C0EA3Q30955590-1E2A9B45-1046-418D-A63C-9992AB68E267Q31125718-59C0D7E5-09F1-43ED-BE98-E07C27EA32DAQ33575029-A9066CC7-6548-40EE-80E1-AC1723DB7D2DQ33623531-D9BBD1FC-3D14-4EDC-8A73-99B457E1966CQ34147541-8305ACAB-1DCB-4130-A72E-EAF18FA25A98Q34347951-3ED388FF-28A1-4A6C-ADDD-972C5BEE83F0Q34445122-078518E8-4A7F-43F9-83CE-3D1C0816E007Q34490921-6727F26F-6781-45D1-A29F-4268C00C8727Q34686623-F4DF4A0A-B4FD-48E4-B9B8-782C7D1FA758Q35164720-D8D3FA54-73F1-4DC3-9470-5CA62151CFC5Q35236749-B3EF8A90-55D9-4784-BADE-58D414A31D6AQ35574525-CD7A3CF5-450D-485A-9EA2-8E4D7259EF24Q35661290-7537FDD9-8EF3-4E72-9DBA-CB61395CB3E8Q35737324-AD53D2CD-B622-4984-A04F-AEA5800C53FCQ35936247-427654F0-2A65-4B53-9FB2-4B37E294FE52Q36031052-83F99274-D808-4C8F-9E4D-6A7D1CF80F2BQ36067322-89BAE8BE-E2B9-45C2-B520-EA08B4363043Q36178492-B45B1C1E-853F-41AD-9850-8624BBFA2F16Q36697477-F96749F7-827A-49DD-9E72-00010CD0A381Q36744050-0FF90EF9-1B2D-412F-970E-4F77C7E3B033Q37029895-9723C3D4-977B-4C6F-BD15-7B8C3E7FEB83Q37079049-3E809201-C75D-491A-B8CE-94BE6CE53707Q37131850-CB6C672C-6DEA-4EA6-8B71-94050CBD4E17Q37365049-C6853E19-E9FB-4713-8F9C-7CF04035EB8BQ37626770-968EEF4C-0E83-4175-9DF1-95B7C3C566BFQ37666548-0CEBFBBD-A79E-43DD-9EE5-A45C0308036CQ37723970-39C81456-450C-46FC-92F8-489468FA273EQ40543401-D528BC88-2006-4AD3-9FCB-7B78D4F0E91BQ45729483-60F76DDF-910E-4BF3-8F48-80894BC8F3B4Q46482999-7CF9AE35-A359-46A0-B397-8BE0ED2AD89CQ47555197-74D76579-CDEF-4F1F-ADD5-A3F1AB959C77Q48792643-8CC1D5F6-7BAF-46D4-BB01-D8C0CEA15C43Q51498641-51792431-9352-4523-9E97-0EB37D10A35DQ51509688-4244253C-61B7-415B-8BB8-425DF1CDE021
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Depression, IV: STAR*D treatment trial for depression.
@ast
Depression, IV: STAR*D treatment trial for depression.
@en
Depression, IV: STAR*D treatment trial for depression.
@nl
type
label
Depression, IV: STAR*D treatment trial for depression.
@ast
Depression, IV: STAR*D treatment trial for depression.
@en
Depression, IV: STAR*D treatment trial for depression.
@nl
prefLabel
Depression, IV: STAR*D treatment trial for depression.
@ast
Depression, IV: STAR*D treatment trial for depression.
@en
Depression, IV: STAR*D treatment trial for depression.
@nl
P2093
P1476
Depression, IV: STAR*D treatment trial for depression.
@en
P2093
A John Rush
Madhukar Trivedi
Maurizio Fava
P356
10.1176/APPI.AJP.160.2.237
P407
P577
2003-02-01T00:00:00Z